Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 9
1959 4
1960 6
1961 4
1962 5
1963 4
1964 4
1965 3
1969 3
1973 1
1974 1
1975 1
1976 1
1977 1
1978 5
1981 1
1982 2
1983 3
1985 1
1989 2
1990 1
1991 1
1992 3
1993 1
1994 2
1995 1
1996 5
1997 2
1998 6
1999 1
2000 3
2001 4
2002 3
2003 1
2004 6
2005 4
2006 5
2007 8
2008 6
2009 9
2010 6
2011 5
2012 4
2013 2
2014 4
2015 2
2016 3
2017 5
2018 8
2019 7
2020 9
2021 14
2022 10
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

191 results
Results by year
Filters applied: . Clear all
Page 1
Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study.
Iaffaldano P, Lucisano G, Manni A, Paolicelli D, Patti F, Capobianco M, Brescia Morra V, Sola P, Pesci I, Lus G, De Luca G, Lugaresi A, Cavalla P, Montepietra S, Maniscalco GT, Granella F, Ragonese P, Vianello M, Brambilla L, Totaro R, Toscano S, Malucchi S, Petracca M, Moiola L, Ferraro D, Lepore V, Mosconi P, Ponzio M, Tedeschi G, Comi G, Battaglia MA, Filippi M, Amato MP, Trojano M; Italian MS Register. Iaffaldano P, et al. Among authors: ragonese p. Neurol Neuroimmunol Neuroinflamm. 2022 Jan 19;9(2):e1141. doi: 10.1212/NXI.0000000000001141. Print 2022 Mar. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 35046084 Free PMC article.
Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple Sclerosis.
Portaccio E, Fonderico M, Iaffaldano P, Pastò L, Razzolini L, Bellinvia A, De Luca G, Ragonese P, Patti F, Brescia Morra V, Cocco E, Sola P, Inglese M, Lus G, Pozzilli C, Maimone D, Lugaresi A, Gazzola P, Comi G, Pesci I, Spitaleri D, Rezzonico M, Vianello M, Avolio C, Logullo FO, Granella F, Salvetti M, Zaffaroni M, Lucisano G, Filippi M, Trojano M, Amato MP; Italian Multiple Sclerosis Register Centers Group. Portaccio E, et al. Among authors: ragonese p. JAMA Neurol. 2022 Sep 1;79(9):869-878. doi: 10.1001/jamaneurol.2022.1929. JAMA Neurol. 2022. PMID: 35877104 Clinical Trial.
Disability assessment using Google Maps.
Lavorgna L, Iaffaldano P, Abbadessa G, Lanzillo R, Esposito S, Ippolito D, Sparaco M, Cepparulo S, Lus G, Viterbo R, Clerico M, Trojsi F, Ragonese P, Borriello G, Signoriello E, Palladino R, Moccia M, Brigo F, Troiano M, Tedeschi G, Bonavita S. Lavorgna L, et al. Among authors: ragonese p. Neurol Sci. 2022 Feb;43(2):1007-1014. doi: 10.1007/s10072-021-05389-7. Epub 2021 Jun 17. Neurol Sci. 2022. PMID: 34142263 Free PMC article.
Correction to: Disability assessment using Google Maps.
Lavorgna L, Iaffaldano P, Abbadessa G, Lanzillo R, Esposito S, Ippolito D, Sparaco M, Cepparulo S, Lus G, Viterbo R, Clerico M, Trojsi F, Ragonese P, Borriello G, Signoriello E, Palladino R, Moccia M, Brigo F, Troiano M, Tedeschi G, Bonavita S. Lavorgna L, et al. Among authors: ragonese p. Neurol Sci. 2022 Feb;43(2):1481. doi: 10.1007/s10072-021-05707-z. Neurol Sci. 2022. PMID: 34727256 Free PMC article. No abstract available.
Mortality in multiple sclerosis: a review.
Ragonese P, Aridon P, Salemi G, D'Amelio M, Savettieri G. Ragonese P, et al. Eur J Neurol. 2008 Feb;15(2):123-7. doi: 10.1111/j.1468-1331.2007.02019.x. Eur J Neurol. 2008. PMID: 18217882 Review.
191 results